INDIVIDUALIZED TREATMENT FOR ALCOHOL-WITHDRAWAL - A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
INDIVIDUALIZED TREATMENT FOR ALCOHOL-WITHDRAWAL - A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
复制标题
DOI:
10.1001/jama.272.7.519
复制
发表时间:
1994-08-17
影响因子:
120.7
通讯作者:
CALKINS, DR
中科院分区:
文献类型:
--
作者:
SAITZ, R;MAYOSMITH, MF;CALKINS, DR
Objective.-To assess the effect of an individualized treatment regimen on the intensity and duration of medication treatment for alcohol withdrawal.Design.-A randomized double-blind, controlled trial.Setting.-An inpatient detoxification unit in a Veterans Affairs medical center.Patients.-One hundred one patients admitted for the treatment of alcohol withdrawal who could give informed consent and had no history of seizures or medication use that might alter the clinical course of withdrawal.Intervention.-Patients were randomized to either a standard course of chlor-diazepoxide four times daily with additional medication as needed (fixed-schedule therapy) or to a treatment regimen that provided chlordiazepoxide only in response to the development of the signs and symptoms of alcohol withdrawal (symptom-triggered therapy). The need for administration of ''as-needed'' medication was determined using a validated measure of the severity of alcohol withdrawal.Main Outcome Measures.-Duration of medication treatment and total chlor-diazepoxide administered.Results.-The median duration of treatment in the symptom-triggered group was 9 hours compared with 68 hours in the fixed-schedule group (P